Expand AKRO Menu

AKRO Stock Summary and Trading Ideas (Akero Therapeutics | NASDAQ:AKRO)

Charts for Today's Stock Price and Implied Volatility in Akero Therapeutics


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AKRO by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Akero Therapeutics (AKRO) Frequently Asked Questions

What does Akero Therapeutics do?

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

What symbol and exchange does Akero Therapeutics stock trade?

Akero Therapeutics trades on the NASDAQ stock market under the symbol AKRO.

What is Akero Therapeutics stock price doing today?

As of February 20, 2024, AKRO stock price climbed to $21.62 with 592,422 million shares trading.

What is Akero Therapeutics's Beta?

AKRO has a beta of 2.29, meaning it tends to be more sensitive to market movements. AKRO has a correlation of 0.05 to the broad based SPY ETF.

How much is Akero Therapeutics worth?

AKRO has a market cap of $1.20 billion. This is considered a Small Cap stock.

What is the highest and lowest price Akero Therapeutics traded in the last 3 year period?

In the last 3 years, AKRO stock traded as high as $58.38 and as low as $7.52.

What are the top ETFs holding Akero Therapeutics?

The top ETF exchange traded funds that AKRO belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWO.

Is Akero Therapeutics (AKRO) a good investment?

AKRO stock has underperformed the market in the last year with a return of -51.7%, while SPY returned +23.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AKRO shares. However, AKRO has outperformed the market in the last 3 month and 2 week periods, returning +49.7% and +3.9%, while SPY returned +10.8% and +0.5%, respectively. This indicates AKRO has been having a stronger performance recently.

What is the support and resistance for Akero Therapeutics (AKRO) stock price?

AKRO support price is $19.90 and resistance is $21.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKRO stock will trade within this expected range on the day.